The use of opioids in severe cancer pain;Bruk av opioider mot sterke kreftrelaterte smerter

Tidsskrift for den Norske Laegeforening

Volumn 124, Issue 3, 2004, Pages 337-338

  Borohgrevink, Petter C ^a   Klepstad, Pål ^a   Kongsgaard, Ulf E ^b   Kaasa, Stein ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BISACODYL; COCODAMOL; FENTANYL; HALOPERIDOL; LACTULOSE; METOCLOPRAMIDE; MORPHINE SULFATE; OPIATE; OXYCODONE; OXYNORM; PARACETAMOL; MORPHINE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CANCER PAIN; CONSTIPATION; DRUG INDICATION; DRUG USE; HUMAN; RESPIRATION DEPRESSION; SHORT SURVEY; SIDE EFFECT; TREATMENT OUTCOME; URINE RETENTION; WORLD HEALTH ORGANIZATION; ARTICLE; NEOPLASM; PAIN; PALLIATIVE THERAPY;

ANALGESICS, OPIOID; FENTANYL; HUMANS; MORPHINE; NEOPLASMS; OXYCODONE; PAIN; PALLIATIVE CARE;

EID: 1442339021     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Klepstad P, Borchgrevink PC, Kaasa S. Effects on cancer patients' health-related quality of life after the start of morphine therapy. J Pain Symptom Manage 2000; 20: 19-26.
2. Doyle D, Hanks G, MacDonald N, red. Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1998.
3. Fitzgibbon DR. Cancer pain: management. I: Loeser JD, red. Bonica's management of pain. Philadelphia: Lippincott, Williams & Wilkins, 2001: 659-702.
4. Cleeland CS, Gonin R, Hatfield AK, Edmondson JH, Blum RH, Stewart JA et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592-6.
5. Melsom H, Wist E. Terminalomsorgen til kreftpasienter. Tidsskr Nor Lægeforen 2001; 121: 2590-2.
6. World Health Organization. Cancer pain relief. Genève: WHO, 1996.
7. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76.
8. Kaasa S, Borchgrevink PC. Definisjon og klassifikasjon av smerte. I: Kaasa S, red. Palliativ behandling og pleie. Oslo: Ad Notam Gyldendal, 1998: 293-304.
9. Hanks GW, De Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ et al. Morphine and alternative opioids in cancer pain: the EACP recommendations. Br J Cancer 2001; 84: 587-93.
10. Klepstad P, Kaasa S, Skauge M, Borchgrevink PC. Pain intensity and side effects during titration of morphine to cancer patients with schedule dose escalation. Acta Anaestesiol Scand 2000; 44: 656-64.
11. Klepstad P, Kaasa S, Jystad Å, Hval B, Borchgrevink PC. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain 2003; 101: 193-8.
12. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273-81.